pyrroles has been researched along with Synovitis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kato, F; Kurosaka, D; Oto, Y; Takahashi, Y | 1 |
| Fearon, U; Gao, W; McCormick, J; McGarry, T; Orr, C; Veale, DJ | 1 |
| Bowes, MA; Bradley, JD; Conaghan, PG; Fuerst, T; Hrycaj, P; Irazoque-Palazuelos, F; Soma, K; Soto-Raices, O; van der Heijde, D; Wilkinson, B; Wu, C; Wyman, BT; Xie, Z; Zhang, R; Østergaard, M | 1 |
| Andersson, S; Bokarewa, M; Brisslert, M; Dehlin, M; Erlandsson, M | 1 |
| Ishii, K; Iwata, S; Kubo, S; Maeshima, K; Miyahara, H; Nakano, K; Ohishi, M; Saito, K; Tanaka, S; Tanaka, Y; Yamaoka, K; Yoshimatsu, H | 1 |
| Jansen, TL | 1 |
1 trial(s) available for pyrroles and Synovitis
| Article | Year |
|---|---|
Comparing the effects of tofacitinib, methotrexate and the combination, on bone marrow oedema, synovitis and bone erosion in methotrexate-naive, early active rheumatoid arthritis: results of an exploratory randomised MRI study incorporating semiquantitati
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Bone Density; Bone Marrow; Bone Marrow Diseases; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Edema; Female; Hand; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Piperidines; Pyrimidines; Pyrroles; Synovitis; Treatment Outcome; Wrist Joint | 2016 |
5 other study(ies) available for pyrroles and Synovitis
| Article | Year |
|---|---|
Alterations of voluntary behavior in the course of disease progress and pharmacotherapy in mice with collagen-induced arthritis.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Disease Models, Animal; Disease Progression; Humans; Joints; Male; Mice, Inbred DBA; Motor Activity; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Synovitis; Temperature | 2019 |
Tofacitinib regulates synovial inflammation in psoriatic arthritis, inhibiting STAT activation and induction of negative feedback inhibitors.
Topics: Adult; Arthritis, Psoriatic; Cell Movement; Cells, Cultured; Female; Fibroblasts; Humans; Inflammation Mediators; Janus Kinase 3; Male; Middle Aged; Molecular Targeted Therapy; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Signal Transduction; STAT Transcription Factors; Synovial Membrane; Synovitis; Tissue Culture Techniques | 2016 |
Inhibition of fms-like tyrosine kinase 3 alleviates experimental arthritis by reducing formation of dendritic cells and antigen presentation.
Topics: Animals; Antigen Presentation; Antineoplastic Agents; Arthritis, Experimental; Autoantibodies; Bone and Bones; Cartilage; Dendritic Cells; fms-Like Tyrosine Kinase 3; Humans; Indoles; Joints; Mice; Mice, Inbred BALB C; Pyrroles; Sunitinib; Synovitis | 2011 |
The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-γ and interleukin-17 production by human CD4+ T cells.
Topics: Animals; Cartilage, Articular; CD4-Positive T-Lymphocytes; Cell Proliferation; Humans; Interferon-gamma; Interleukin-17; Janus Kinase 3; Mice; Monocytes; Piperidines; Pyrimidines; Pyrroles; Synovial Membrane; Synovitis | 2012 |
Atorvastatine for chronic synovitis due to massive intra-articular cholesterol monohydrate deposition in long-standing rheumatoid arthritis.
Topics: Anticholesteremic Agents; Arthritis, Rheumatoid; Atorvastatin; Cholesterol; Crystallization; Female; Heptanoic Acids; Humans; Middle Aged; Pyrroles; Synovitis | 2006 |